AcelRx Pharmaceuticals, Inc. carries a market capitalization of 14.58M, placing it among publicly traded companies globally.
| Market Cap | 14.58M |
| Enterprise Value | N/A |
AcelRx Pharmaceuticals, Inc.'s stock has declined approximately -55.6701% over the past 52 weeks. The 50-day moving average sits at 0.76, while the 200-day moving average is 0.84.
| Beta (5Y) | N/A |
| 52-Week Price Change | -55.6701% |
| 50-Day Moving Average | 0.76 |
| 200-Day Moving Average | 0.84 |
| Average Volume (20 Days) | N/A |
AcelRx Pharmaceuticals, Inc.'s most recent stock split took place on October 26, 2022 with a 20:1 split ratio.
| Last Split Date | 10/26/2022 |
| Split Ratio | 20:1 |